 | • レポートコード：QYR9ST03871 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、血液疾患用薬物および診断の世界市場について調査・分析し、血液疾患用薬物および診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（分析装置、試薬）、用途別（学術研究所、ポイントオブケア検査、患者セルフテスト、バイオ医薬品産業、病院、臨床検査室）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血液疾患用薬物および診断市場動向 ・主要企業別マーケットシェア ・血液疾患用薬物および診断の種類別市場規模2014-2019 （分析装置、試薬） ・血液疾患用薬物および診断の用途別市場規模2014-2019 （学術研究所、ポイントオブケア検査、患者セルフテスト、バイオ医薬品産業、病院、臨床検査室） ・血液疾患用薬物および診断の北米市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断の中国市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断の日本国内市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断のインド市場：主要企業・種類別/用途別市場規模 ・血液疾患用薬物および診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbot、Pfizer、Amgen、Beckman Coulter、Mindray、Roche、Biorad、Eli Lilly、Sysmex、Bristol-Myers、Siemens、Horbia、Nihon Kohden） ・血液疾患用薬物および診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood.Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells to decrease such as leukocytosis and thrombocytosis. The modern approach of using point of care diagnostics, cytometry techniques in hematological disorder diagnosis have outpaced the traditional methods because they can be used even in the absence of healthcare personnel and in extreme conditions.
In 2018, the global Drugs and Diagnostics for Hematological Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Drugs and Diagnostics for Hematological Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs and Diagnostics for Hematological Disorders development in United States, Europe and China.
The key players covered in this study
Abbot
Pfizer
Amgen
Beckman Coulter
Mindray
Roche
Biorad
Eli Lilly
Sysmex
Bristol-Myers
Siemens
Horbia
Nihon Kohden
Market segment by Type, the product can be split into
Analyzers
Reagents
Market segment by Application, split into
Academic and Research Institute
Point of Care Testing
Patient Self-testing
Biopharmaceutical Industries
Hospitals
Clinical Laboratories
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Drugs and Diagnostics for Hematological Disorders status, future forecast, growth opportunity, key market and key players.
To present the Drugs and Diagnostics for Hematological Disorders development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Drugs and Diagnostics for Hematological Disorders are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drugs and Diagnostics for Hematological Disorders Market Size Growth Rate by Type (2014-2025)
1.4.2 Analyzers
1.4.3 Reagents
1.5 Market by Application
1.5.1 Global Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2025)
1.5.2 Academic and Research Institute
1.5.3 Point of Care Testing
1.5.4 Patient Self-testing
1.5.5 Biopharmaceutical Industries
1.5.6 Hospitals
1.5.7 Clinical Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Drugs and Diagnostics for Hematological Disorders Market Size
2.2 Drugs and Diagnostics for Hematological Disorders Growth Trends by Regions
2.2.1 Drugs and Diagnostics for Hematological Disorders Market Size by Regions (2014-2025)
2.2.2 Drugs and Diagnostics for Hematological Disorders Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Drugs and Diagnostics for Hematological Disorders Market Size by Manufacturers
3.1.1 Global Drugs and Diagnostics for Hematological Disorders Revenue by Manufacturers (2014-2019)
3.1.2 Global Drugs and Diagnostics for Hematological Disorders Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Drugs and Diagnostics for Hematological Disorders Market Concentration Ratio (CR5 and HHI)
3.2 Drugs and Diagnostics for Hematological Disorders Key Players Head office and Area Served
3.3 Key Players Drugs and Diagnostics for Hematological Disorders Product/Solution/Service
3.4 Date of Enter into Drugs and Diagnostics for Hematological Disorders Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019)
4.2 Global Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019)
5 United States
5.1 United States Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
5.2 Drugs and Diagnostics for Hematological Disorders Key Players in United States
5.3 United States Drugs and Diagnostics for Hematological Disorders Market Size by Type
5.4 United States Drugs and Diagnostics for Hematological Disorders Market Size by Application
6 Europe
6.1 Europe Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
6.2 Drugs and Diagnostics for Hematological Disorders Key Players in Europe
6.3 Europe Drugs and Diagnostics for Hematological Disorders Market Size by Type
6.4 Europe Drugs and Diagnostics for Hematological Disorders Market Size by Application
7 China
7.1 China Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
7.2 Drugs and Diagnostics for Hematological Disorders Key Players in China
7.3 China Drugs and Diagnostics for Hematological Disorders Market Size by Type
7.4 China Drugs and Diagnostics for Hematological Disorders Market Size by Application
8 Japan
8.1 Japan Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
8.2 Drugs and Diagnostics for Hematological Disorders Key Players in Japan
8.3 Japan Drugs and Diagnostics for Hematological Disorders Market Size by Type
8.4 Japan Drugs and Diagnostics for Hematological Disorders Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
9.2 Drugs and Diagnostics for Hematological Disorders Key Players in Southeast Asia
9.3 Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size by Type
9.4 Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size by Application
10 India
10.1 India Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
10.2 Drugs and Diagnostics for Hematological Disorders Key Players in India
10.3 India Drugs and Diagnostics for Hematological Disorders Market Size by Type
10.4 India Drugs and Diagnostics for Hematological Disorders Market Size by Application
11 Central & South America
11.1 Central & South America Drugs and Diagnostics for Hematological Disorders Market Size (2014-2019)
11.2 Drugs and Diagnostics for Hematological Disorders Key Players in Central & South America
11.3 Central & South America Drugs and Diagnostics for Hematological Disorders Market Size by Type
11.4 Central & South America Drugs and Diagnostics for Hematological Disorders Market Size by Application
12 International Players Profiles
12.1 Abbot
12.1.1 Abbot Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.1.4 Abbot Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.1.5 Abbot Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.2.4 Pfizer Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.3.4 Amgen Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.3.5 Amgen Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.4.4 Beckman Coulter Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.4.5 Beckman Coulter Recent Development
12.5 Mindray
12.5.1 Mindray Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.5.4 Mindray Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.5.5 Mindray Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.6.4 Roche Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Biorad
12.7.1 Biorad Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.7.4 Biorad Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.7.5 Biorad Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.8.4 Eli Lilly Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Sysmex
12.9.1 Sysmex Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.9.4 Sysmex Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.9.5 Sysmex Recent Development
12.10 Bristol-Myers
12.10.1 Bristol-Myers Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drugs and Diagnostics for Hematological Disorders Introduction
12.10.4 Bristol-Myers Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
12.10.5 Bristol-Myers Recent Development
12.11 Siemens
12.12 Horbia
12.13 Nihon Kohden
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Drugs and Diagnostics for Hematological Disorders Key Market Segments
Table Key Players Drugs and Diagnostics for Hematological Disorders Covered
Table Global Drugs and Diagnostics for Hematological Disorders Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size Market Share by Type 2014-2025
Figure Analyzers Figures
Table Key Players of Analyzers
Figure Reagents Figures
Table Key Players of Reagents
Table Global Drugs and Diagnostics for Hematological Disorders Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic and Research Institute Case Studies
Figure Point of Care Testing Case Studies
Figure Patient Self-testing Case Studies
Figure Biopharmaceutical Industries Case Studies
Figure Hospitals Case Studies
Figure Clinical Laboratories Case Studies
Figure Drugs and Diagnostics for Hematological Disorders Report Years Considered
Table Global Drugs and Diagnostics for Hematological Disorders Market Size 2014-2025 (Million US$)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Regions 2014-2025 (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Regions 2014-2019 (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Share by Regions 2014-2019
Figure Global Drugs and Diagnostics for Hematological Disorders Market Share by Regions 2014-2019
Figure Global Drugs and Diagnostics for Hematological Disorders Market Share by Regions 2019
Table Market Top Trends
Table Global Drugs and Diagnostics for Hematological Disorders Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Share by Manufacturers (2014-2019)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Share by Manufacturers in 2018
Table Global Drugs and Diagnostics for Hematological Disorders Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Drugs and Diagnostics for Hematological Disorders Product/Solution/Service
Table Date of Enter into Drugs and Diagnostics for Hematological Disorders Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size Share by Type (2014-2019)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size Market Share by Type (2014-2019)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size Share by Application (2014-2019)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size Market Share by Application (2014-2019)
Figure Global Drugs and Diagnostics for Hematological Disorders Revenue Market Share by Application in 2018
Figure United States Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table United States Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table United States Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table United States Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table United States Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table United States Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table United States Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure Europe Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table Europe Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table Europe Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table Europe Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table Europe Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table Europe Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table Europe Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure China Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table China Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table China Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table China Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-20189) (Million US$)
Table China Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table China Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table China Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure Japan Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table Japan Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table Japan Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table Japan Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table Japan Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table Japan Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table Japan Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure India Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table India Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table India Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table India Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table India Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table India Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table India Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Figure Central & South America Drugs and Diagnostics for Hematological Disorders Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Drugs and Diagnostics for Hematological Disorders Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Drugs and Diagnostics for Hematological Disorders Market Share (2018-2019)
Table Central & South America Drugs and Diagnostics for Hematological Disorders Market Size by Type (2014-2019) (Million US$)
Table Central & South America Drugs and Diagnostics for Hematological Disorders Market Share by Type (2014-2019)
Table Central & South America Drugs and Diagnostics for Hematological Disorders Market Size by Application (2014-2019) (Million US$)
Table Central & South America Drugs and Diagnostics for Hematological Disorders Market Share by Application (2014-2019)
Table Abbot Company Details
Table Abbot Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019) (Million US$)
Figure Abbot Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Abbot Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Amgen Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Beckman Coulter Recent Development
Table Mindray Company Details
Table Mindray Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Mindray Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Mindray Recent Development
Table Roche Company Details
Table Roche Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Roche Recent Development
Table Biorad Company Details
Table Biorad Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Biorad Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Biorad Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Eli Lilly Recent Development
Table Sysmex Company Details
Table Sysmex Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Sysmex Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Sysmex Recent Development
Table Bristol-Myers Company Details
Table Bristol-Myers Revenue in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)(Million US$)
Figure Bristol-Myers Revenue Growth Rate in Drugs and Diagnostics for Hematological Disorders Business (2014-2019)
Table Bristol-Myers Recent Development
Table Siemens Company Details
Table Horbia Company Details
Table Nihon Kohden Company Details
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Regions (Million US$) 2019-2025
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size Share by Regions (2019-2025)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size Share by Regions in 2025
Figure United States Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Europe Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure China Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Japan Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure India Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Drugs and Diagnostics for Hematological Disorders Market Size Forecast (2019-2025)(Million USD)
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Product (2019-2025) (Million US$)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size by Product (2019-2025)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size by Product in 2025
Table Global Drugs and Diagnostics for Hematological Disorders Market Size by Application (2019-2025) (Million US$)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size by Application (2019-2025)
Figure Global Drugs and Diagnostics for Hematological Disorders Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
血液疾患診断及び治療の世界市場：市場規模・現状・予測 Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…- 世界のポイントオブケアテスト（POCT）デバイス市場：専門的調査 Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which all…
- 非血液癌の世界市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…
- ポイントオブケア分子診断の世界市場：市場規模・現状・予測 Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the market growth. In 2018, the glob…
- 血液悪性腫瘍の世界市場：市場規模・現状・予測 Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.In 2018, the global Hematological Malignancies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, wit…